• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Latest News

Gilead, Xilio Therapeutics Ink Exclusive Licensing Agreement to Develop Early Phase  Tumor-Activated IL-12
Gilead, Xilio Therapeutics Ink Exclusive Licensing Agreement to Develop Early Phase Tumor-Activated IL-12

March 29th 2024

Deal aims to commercialize XTX301 for treating advanced solid tumors by leveraging Xilio’s tumor-activated immuno-oncology therapies.

Fierce Females in the Life Science Space
Fierce Females in the Life Science Space

March 29th 2024

Rebecca Marquez
Adapting to Remote Workers and Services: Q&A with Rebecca Marquez, Director of Custom Research at PMMI

March 29th 2024

stock.adobe.com
Minnesota Bill Would Increase Access to Genetic Testing

March 29th 2024

Conference Coverage

View All
Image credit: Design Cells | stock.adobe.com
Novartis' Lutathera Shows Significant Survival Benefit as First-Line Treatment for GEP-NETs

January 19th 2024

Eisai
Eisai To Present New Data For Gastrointestinal Cancer Research at ASCO GI 2024

January 17th 2024

Image credit: Lucky Ai | stock.adobe.com
Presentation at J.P. Morgan Healthcare Conference Highlights Growth of Platform for AI, Data

January 15th 2024

stock.adobe.com
Dexcom Announces Preliminary and Unaudited Revenue For Fourth Quarter and Fiscal Year 2023

January 12th 2024

Latest Videos
Podcasts

All News